July 11-12 open meeting of the FDA advisory committee chaired by Charles Edwards -- also known as the "blue ribbon panel" -- will be held in Washington, D.C. at the Madison Hotel, 15th and M Sts. N.W., beginning at 9 a.m. both days.
You may also be interested in...
Company is confident that data readout from pivotal trial could be ready before the end of 2020.
This is an update of recommendations from the European Medicines Agency's Committee for Medicinal Products for Human Use on the authorization of new medicines in the European Union, and updates on EU marketing authorization changes recommended by the CHMP.
Cognoa said it will submit its AI-powered digital app for early detection of autism for de novo clearance with the US FDA. See what the company’s senior medical director of clinical adoption said about it here.